www.pharmablog.nl
Weblog met nieuws over de pharmaceutische industrie
Archive for the ‘Uncategorized’ Category
GlaxoSmithKline cuts some ties to bowel drug
Author: admin3 Sep
GlaxoSmithKline has scaled back its development agreement for the gastrointestinal drug Entereg. (GSK)
FDA refuses Introgen application; stock in freefall
Author: admin3 Sep
Introgen Therapeutics Inc.’s stock plummeted Tuesday after the company announced that the U.S. Food and Drug Administration has refused to accept its application to begin marketing its flagship cancer drug.
Histogenics raises $9 million
Author: admin3 Sep
Cartilage regeneration company Histogenics Corp. has raised $9 million in a second round of venture financing that will help fuel clinical trials for its signature products.
Burnham awarded $97.9M for molecule screening center
Author: admin3 Sep
The Burnham Institute for Medical Research has been awarded a six-year, $97.9 million grant from the National Institutes of Health.
VUMC to research blood pressure medication’s effect on Type 2 diabetes
Author: admin3 Sep
Vanderbilt University Medical Center diabetes researchers have launched a study examining whether a commonly prescribed blood pressure medication for treating high might help prevent or delay the onset of Type 2 diabetes.
Oncothyreon to sell 5.1 million shares to raise nearly $12M
Author: admin3 Sep
Oncothyroen Inc. said it plans to sell 5.1 million shares of its stock in an effort to raise approximately $12 million. (ONTY)
University of New Mexico named molecular discovery center
Author: admin3 Sep
The University of New Mexico has been selected by the National Institutes of Health as one of only nine national molecular discovery centers in the U.S., and awarded a six-year, $15.5 million grant.
Transcept Pharmaceuticals to merge with Novacea, move sleep drug forward
Author: admin3 Sep
Novacea Inc. of South San Francisco and privately held Transcept Pharmaceuticals Inc. of Richmond will merge, blending a company with a recently failed Big Pharma collaboration with one on the verge of seeking FDA approval for its first drug. (NOVC) (SGP) (SNY) (HTGC) (DNA)
Louisville researchers land $1.4 million grant to speed testing of heart device
Author: admin3 Sep
Scientists at the Cardiovascular Innovation Institute and Louisville bioservices company SCR Inc. have received a $1.4 million federal grant to help develop and bring to market a new device to treat congestive heart failure.
Group acquires Ivax Diagnostics
Author: admin3 Sep
Ivax Diagnostics announced Tuesday that a group, controlled by entrepreneurs Paul Kennedy and Patrice Debregeas, purchased all of the nearly 72 percent of the outstanding shares of Ivax Diagnostics from Teva Pharmaceutical Industries Ltd. for $14 million, or 70 cents a share.